Paper32292575
Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.
Lamb DJ and 10 others. Oncotarget, 2020. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells. Papers, record 32292575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32292575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH |
Source NIH RePORTER
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24779514 | Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. | J Med Chem | 2014 | https://conductscience.org/library/papers/24779514 | PubMed |
| 2 | 26707592 | A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). | Eur J Cancer | 2016 | https://conductscience.org/library/papers/26707592 | PubMed |
| 3 | 22864779 | Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report. | Pol J Pathol | 2012 | https://conductscience.org/library/papers/22864779 | PubMed |
| 4 | 24975478 | Getting Syk: spleen tyrosine kinase as a therapeutic target. | Trends Pharmacol Sci | 2014 | https://conductscience.org/library/papers/24975478 | PubMed |
| 5 | 27014261 | Targeting Syk in Autoimmune Rheumatic Diseases. | Front Immunol | 2016 | https://conductscience.org/library/papers/27014261 | PubMed |
| 6 | 29855199 | Targeting the B cell receptor pathway in non-Hodgkin lymphoma. | Expert Opin Investig Drugs | 2018 | https://conductscience.org/library/papers/29855199 | PubMed |
| 7 | 23154170 | Structural and biophysical characterization of the Syk activation switch. | J Mol Biol | 2013 | https://conductscience.org/library/papers/23154170 | PubMed |
| 8 | 26582197 | FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26582197 | PubMed |
| 9 | 28721362 | Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014. | NPJ Breast Cancer | 2015 | https://conductscience.org/library/papers/28721362 | PubMed |
| 10 | 11454707 | Hypermethylation leads to silencing of the SYK gene in human breast cancer. | Cancer Res | 2001 | https://conductscience.org/library/papers/11454707 | PubMed |
| 11 | 19829710 | Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. | PLoS One | 2009 | https://conductscience.org/library/papers/19829710 | PubMed |
| 12 | 19199943 | Tyrosine kinases and inflammatory signalling. | Curr Mol Med | 2009 | https://conductscience.org/library/papers/19199943 | PubMed |
| 13 | 27048659 | BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/27048659 | PubMed |
| 14 | 24523870 | SYK allelic loss and the role of Syk-regulated genes in breast cancer survival. | PLoS One | 2014 | https://conductscience.org/library/papers/24523870 | PubMed |
| 15 | 27363440 | Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/27363440 | PubMed |
| 16 | 18048647 | ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. | Blood | 2008 | https://conductscience.org/library/papers/18048647 | PubMed |
| 17 | 20628393 | A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20628393 | PubMed |
| 18 | 23251529 | Spontaneous production of immunoglobulin M in human epithelial cancer cells. | PLoS One | 2012 | https://conductscience.org/library/papers/23251529 | PubMed |
| 19 | 9050992 | p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. | Oncogene | 1997 | https://conductscience.org/library/papers/9050992 | PubMed |
| 20 | 11676469 | Syk expression and novel function in a wide variety of tissues. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11676469 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37760847 | Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines. | Biomedicines | 2023 | https://conductscience.org/library/papers/37760847 | PubMed |
| 36568669 | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases. | Heliyon | 2022 | https://conductscience.org/library/papers/36568669 | PubMed |
| 33407076 | MiBiOmics: an interactive web application for multi-omics data exploration and integration. | BMC Bioinformatics | 2021 | https://conductscience.org/library/papers/33407076 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32292575
GET https://conductscience.org/api/papers/v1/32292575/references?page=2